Search Results - "Guérin, Viviane"
-
1
Anti-endothelial cell autoantibodies and soluble markers of endothelial cell dysfunction in systemic lupus erythematosus
Published in Journal of rheumatology (01-09-2003)“…OBJECTIVE: To determine if anti-endothelial cell antibodies (AECA) and plasma markers of endothelial cell function are related to disease severity in systemic…”
Get full text
Journal Article -
2
Novel risk factors for premature peripheral arterial occlusive disease in non-diabetic patients: a case-control study
Published in PloS one (22-03-2013)“…This study aimed to determine the prevalence of genetic and environmental vascular risk factors in non diabetic patients with premature peripheral arterial…”
Get full text
Journal Article -
3
Coagulopathies frequency in aseptic osteonecrosis patients
Published in Joint, bone, spine : revue du rhumatisme (01-03-2009)“…Abstract Many risk factors of aseptic osteonecrosis (AO) are well-known, even if 40% of events are idiopathic. Intravascular thrombosis is one of the…”
Get full text
Journal Article -
4
Compliance with Early Long-Term Prophylaxis Guidelines for Severe Hemophilia A
Published in The Journal of pediatrics (01-07-2021)“…To evaluate the applicability and compliance with guidelines for early initiation of long-term prophylaxis in infants with severe hemophilia A and to identify…”
Get full text
Journal Article -
5
Acquired haemophilia A associated with transitory and severe factor V deficiency during bullous pemphigoid: first report
Published in Thrombosis and haemostasis (01-03-2009)Get more information
Journal Article -
6
Compliance with Early Long-Term Prophylaxis Guidelines for Severe Hemophilia A
Published in The Journal of pediatrics (01-07-2021)Get full text
Journal Article -
7
FEIBA in the treatment of acquired haemophilia A: Results from the prospective multicentre French 'FEIBA dans l'hémophilie A acquise' (FEIBHAC) registry
Published in Haemophilia : the official journal of the World Federation of Hemophilia (01-05-2015)“…Summary Factor VIII inhibitor bypass activity (FEIBA) is a recommended first‐line bypassing agent for bleeding episodes in patients with acquired haemophilia A…”
Get full text
Journal Article -
8
Effects of armagnac extracts on human platelet function in vitro and on rat arteriovenous shunt thrombosis in vivo
Published in Thrombosis research (01-05-2003)“…Introduction: The “French paradox”, a low cardiovascular mortality compared to the prevalent risk factors, has been attributed to the regular use of red wine,…”
Get full text
Journal Article -
9
Intracranial haemorrhages in French haemophilia patients (1991-2001): clinical presentation, management and prognosis factors for death
Published in Haemophilia : the official journal of the World Federation of Hemophilia (01-09-2005)“…Intracranial haemorrhage (ICH) is known to be a severe although uncommon complication of haemophilia. A national survey has been conducted in France in order…”
Get full text
Journal Article -
10
Protein C and protein S assessment in hospital laboratories: which strategy and what role for DNA sequencing?
Published in Blood coagulation & fibrinolysis (01-09-2003)“…This paper presents a critical assessment of protein C (PC) and protein S (PS) functional and immunological approaches with regard to DNA sequencing in a large…”
Get full text
Journal Article -
11
Three months supplementation of hyperhomocysteinaemic patients with folic acid and vitamin B6 improves biological markers of endothelial dysfunction
Published in British journal of haematology (01-12-1999)“…Hyperhomocysteinaemia is a risk factor for premature atherosclerosis and venous thromboembolic disease. Supplementation with folic acid and vitamin B6 has been…”
Get full text
Journal Article -
12
Recombinant FVIIa in the treatment of bleeding in acquired hemophilia
Published in American journal of hematology (01-08-2002)Get full text
Journal Article -
13
Ostéonécrose aseptique : fréquence des coagulopathies
Published in Revue du rhumatisme (Ed. française : 1993) (2009)“…Bien que de nombreux facteurs de risque aient été décrits au cours de l’ostéonécrose aseptique (ON), le bilan étiologique n’identifie aucun de ces facteurs…”
Get full text
Journal Article -
14
Factor XI replacement for inherited factor XI deficiency in routine clinical practice: results of the HEMOLEVEN prospective 3-year postmarketing study
Published in Haemophilia : the official journal of the World Federation of Hemophilia (01-07-2015)“…Summary Factor XI (FXI)‐deficient patients may develop excessive bleeding after trauma or surgery. Replacement therapy should be considered in high‐risk…”
Get full text
Journal Article -
15
Endothelial dysfunction during acute methionine load in hyperhomocysteinaemic patients
Published in Atherosclerosis (01-12-1999)“…Hyperhomocysteinaemia has been associated with arterial and venous thrombosis possibly by causing damage to the endothelium. We hypothesised that an oral load…”
Get full text
Journal Article -
16
-
17
FranceCoag Network: A National Multicenter Prospective Cohort for Congenital Bleeding Disorders
Published in Blood (16-11-2005)“…The FranceCoag Network is a prospective national cohort of patients affected with hemophilia and severe hereditary hemorrhagic diseases except platelet…”
Get full text
Journal Article -
18
Novel Risk Factors for Premature Peripheral Arterial Occlusive Disease in Non-Diabetic Patients: A Case-Control Study. e37882
Published in PloS one (01-03-2013)“…Background This study aimed to determine the prevalence of genetic and environmental vascular risk factors in non diabetic patients with premature peripheral…”
Get full text
Journal Article -
19
Efficiency of alteplase in the treatment of venous and arterial thrombosis in neonates
Published in American journal of hematology (01-02-1993)Get more information
Journal Article -
20
High level of plasmatic von Willebrand factor limits the bleeding time in thrombopenic HIV-infected patients
Published in Thrombosis and haemostasis (01-08-1995)Get more information
Journal Article